BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1535 related articles for article (PubMed ID: 32025007)

  • 1. Pan-cancer analysis of whole genomes.
    ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
    Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
    Cortés-Ciriano I; Lee JJ; Xi R; Jain D; Jung YL; Yang L; Gordenin D; Klimczak LJ; Zhang CZ; Pellman DS; ; Park PJ;
    Nat Genet; 2020 Mar; 52(3):331-341. PubMed ID: 32025003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of somatic structural variation in human cancer genomes.
    Li Y; Roberts ND; Wala JA; Shapira O; Schumacher SE; Kumar K; Khurana E; Waszak S; Korbel JO; Haber JE; Imielinski M; ; Weischenfeldt J; Beroukhim R; Campbell PJ;
    Nature; 2020 Feb; 578(7793):112-121. PubMed ID: 32025012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.
    Rheinbay E; Nielsen MM; Abascal F; Wala JA; Shapira O; Tiao G; Hornshøj H; Hess JM; Juul RI; Lin Z; Feuerbach L; Sabarinathan R; Madsen T; Kim J; Mularoni L; Shuai S; Lanzós A; Herrmann C; Maruvka YE; Shen C; Amin SB; Bandopadhayay P; Bertl J; Boroevich KA; Busanovich J; Carlevaro-Fita J; Chakravarty D; Chan CWY; Craft D; Dhingra P; Diamanti K; Fonseca NA; Gonzalez-Perez A; Guo Q; Hamilton MP; Haradhvala NJ; Hong C; Isaev K; Johnson TA; Juul M; Kahles A; Kahraman A; Kim Y; Komorowski J; Kumar K; Kumar S; Lee D; Lehmann KV; Li Y; Liu EM; Lochovsky L; Park K; Pich O; Roberts ND; Saksena G; Schumacher SE; Sidiropoulos N; Sieverling L; Sinnott-Armstrong N; Stewart C; Tamborero D; Tubio JMC; Umer HM; Uusküla-Reimand L; Wadelius C; Wadi L; Yao X; Zhang CZ; Zhang J; Haber JE; Hobolth A; Imielinski M; Kellis M; Lawrence MS; von Mering C; Nakagawa H; Raphael BJ; Rubin MA; Sander C; Stein LD; Stuart JM; Tsunoda T; Wheeler DA; Johnson R; Reimand J; Gerstein M; Khurana E; Campbell PJ; López-Bigas N; ; ; Weischenfeldt J; Beroukhim R; Martincorena I; Pedersen JS; Getz G;
    Nature; 2020 Feb; 578(7793):102-111. PubMed ID: 32025015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020.
    Giunta S
    Cancer Metastasis Rev; 2021 Sep; 40(3):909-924. PubMed ID: 34097189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolutionary history of 2,658 cancers.
    Gerstung M; Jolly C; Leshchiner I; Dentro SC; Gonzalez S; Rosebrock D; Mitchell TJ; Rubanova Y; Anur P; Yu K; Tarabichi M; Deshwar A; Wintersinger J; Kleinheinz K; Vázquez-García I; Haase K; Jerman L; Sengupta S; Macintyre G; Malikic S; Donmez N; Livitz DG; Cmero M; Demeulemeester J; Schumacher S; Fan Y; Yao X; Lee J; Schlesner M; Boutros PC; Bowtell DD; Zhu H; Getz G; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Markowetz F; Mustonen V; Yuan K; Wang W; Morris QD; ; Spellman PT; Wedge DC; Van Loo P;
    Nature; 2020 Feb; 578(7793):122-128. PubMed ID: 32025013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome sequencing with long reads reveals complex structure and origin of structural variation in human genetic variations and somatic mutations in cancer.
    Fujimoto A; Wong JH; Yoshii Y; Akiyama S; Tanaka A; Yagi H; Shigemizu D; Nakagawa H; Mizokami M; Shimada M
    Genome Med; 2021 Apr; 13(1):65. PubMed ID: 33910608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the exome: the role of non-coding somatic mutations in cancer.
    Piraino SW; Furney SJ
    Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathway and network analysis of more than 2500 whole cancer genomes.
    Reyna MA; Haan D; Paczkowska M; Verbeke LPC; Vazquez M; Kahraman A; Pulido-Tamayo S; Barenboim J; Wadi L; Dhingra P; Shrestha R; Getz G; Lawrence MS; Pedersen JS; Rubin MA; Wheeler DA; Brunak S; Izarzugaza JMG; Khurana E; Marchal K; von Mering C; Sahinalp SC; Valencia A; ; Reimand J; Stuart JM; Raphael BJ;
    Nat Commun; 2020 Feb; 11(1):729. PubMed ID: 32024854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A user guide for the online exploration and visualization of PCAWG data.
    Goldman MJ; Zhang J; Fonseca NA; Cortés-Ciriano I; Xiang Q; Craft B; Piñeiro-Yáñez E; O'Connor BD; Bazant W; Barrera E; Muñoz-Pomer A; Petryszak R; Füllgrabe A; Al-Shahrour F; Keays M; Haussler D; Weinstein JN; Huber W; Valencia A; Park PJ; Papatheodorou I; Zhu J; Ferretti V; Vazquez M
    Nat Commun; 2020 Jul; 11(1):3400. PubMed ID: 32636365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic footprints of activated telomere maintenance mechanisms in cancer.
    Sieverling L; Hong C; Koser SD; Ginsbach P; Kleinheinz K; Hutter B; Braun DM; Cortés-Ciriano I; Xi R; Kabbe R; Park PJ; Eils R; Schlesner M; ; Brors B; Rippe K; Jones DTW; Feuerbach L;
    Nat Commun; 2020 Feb; 11(1):733. PubMed ID: 32024817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic basis for RNA alterations in cancer.
    ; Calabrese C; Davidson NR; Demircioğlu D; Fonseca NA; He Y; Kahles A; Lehmann KV; Liu F; Shiraishi Y; Soulette CM; Urban L; Greger L; Li S; Liu D; Perry MD; Xiang Q; Zhang F; Zhang J; Bailey P; Erkek S; Hoadley KA; Hou Y; Huska MR; Kilpinen H; Korbel JO; Marin MG; Markowski J; Nandi T; Pan-Hammarström Q; Pedamallu CS; Siebert R; Stark SG; Su H; Tan P; Waszak SM; Yung C; Zhu S; Awadalla P; Creighton CJ; Meyerson M; Ouellette BFF; Wu K; Yang H; ; Brazma A; Brooks AN; Göke J; Rätsch G; Schwarz RF; Stegle O; Zhang Z;
    Nature; 2020 Feb; 578(7793):129-136. PubMed ID: 32025019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The repertoire of mutational signatures in human cancer.
    Alexandrov LB; Kim J; Haradhvala NJ; Huang MN; Tian Ng AW; Wu Y; Boot A; Covington KR; Gordenin DA; Bergstrom EN; Islam SMA; Lopez-Bigas N; Klimczak LJ; McPherson JR; Morganella S; Sabarinathan R; Wheeler DA; Mustonen V; ; Getz G; Rozen SG; Stratton MR;
    Nature; 2020 Feb; 578(7793):94-101. PubMed ID: 32025018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence, functionality and abundance of the TERT promoter mutations.
    Rachakonda S; Hoheisel JD; Kumar R
    Int J Cancer; 2021 Dec; 149(11):1852-1862. PubMed ID: 34313327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined burden and functional impact tests for cancer driver discovery using DriverPower.
    Shuai S; ; Gallinger S; Stein LD;
    Nat Commun; 2020 Feb; 11(1):734. PubMed ID: 32024818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
    Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
    Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences.
    Kumar S; Warrell J; Li S; McGillivray PD; Meyerson W; Salichos L; Harmanci A; Martinez-Fundichely A; Chan CWY; Nielsen MM; Lochovsky L; Zhang Y; Li X; Lou S; Pedersen JS; Herrmann C; Getz G; Khurana E; Gerstein MB
    Cell; 2020 Mar; 180(5):915-927.e16. PubMed ID: 32084333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
    Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
    Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
    Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
    Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in oncogenic mutational processes.
    Li CH; Prokopec SD; Sun RX; Yousif F; Schmitz N; ; Boutros PC;
    Nat Commun; 2020 Aug; 11(1):4330. PubMed ID: 32859912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.